APO Research
Talk to an analyst

APO RESEARCH · REPORT

Wilms Tumor Protein

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Wilms Tumor Protein Industry Growth and Trends Forecast to 2032

19 December 202592 pages

Choose your research edition.

Industry ResearchWilms Tumor Protein Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Wilms Tumor Protein Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Wilms Tumor Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Wilms Tumor Protein Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Wilms Tumor Protein Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Wilms Tumor Protein market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Wilms Tumor Protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Wilms Tumor Protein is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Wilms Tumor Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Wilms Tumor Protein include Sumitomo Dainippon Pharma Co Ltd, GlaxoSmithKline Plc, Vaximm AG, Sellas Life Sciences Group Ltd, Otsuka Holdings Co Ltd and Inovio Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Wilms Tumor Protein market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Wilms Tumor Protein market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Wilms Tumor Protein market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Wilms Tumor Protein.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Wilms Tumor Protein market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Wilms Tumor Protein Market by Company

Sumitomo Dainippon Pharma Co Ltd

GlaxoSmithKline Plc

Vaximm AG

Sellas Life Sciences Group Ltd

Otsuka Holdings Co Ltd

Inovio Pharmaceuticals Inc

Wilms Tumor Protein Segment by Type

OCV-501

INO-5401

GSK-2130579A

Galinpepimut-S

Elatipepimut-S

Others

Wilms Tumor Protein Segment by Application

Adrenal Gland Cancer

High-Grade Glioma

Peritoneal Cancer

Lung Cancer

Others

Wilms Tumor Protein Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wilms Tumor Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Wilms Tumor Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wilms Tumor Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Wilms Tumor Protein manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Wilms Tumor Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of OCV-501 Table 2. Major Company of INO-5401 Table 3. Major Company of GSK-2130579A Table 4. Major Company of Galinpepimut-S Table 5. Major Company of Elatipepimut-S Table 6. Major Company of Others Table 7. Global Wilms Tumor Protein Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Wilms Tumor Protein Sales by Type (2021-2026) & (K Units) Table 9. Global Wilms Tumor Protein Sales Market Share in Volume by Type (2021-2026) Table 10. Global Wilms Tumor Protein Sales by Type (2021-2026) & (US$ Million) Table 11. Global Wilms Tumor Protein Sales Market Share in Value by Type (2021-2026) Table 12. Global Wilms Tumor Protein Price by Type (2021-2026) & (US$/Unit) Table 13. Global Wilms Tumor Protein Sales by Type (2027-2032) & (K Units) Table 14. Global Wilms Tumor Protein Sales Market Share in Volume by Type (2027-2032) Table 15. Global Wilms Tumor Protein Sales by Type (2027-2032) & (US$ Million) Table 16. Global Wilms Tumor Protein Sales Market Share in Value by Type (2027-2032) Table 17. Global Wilms Tumor Protein Price by Type (2027-2032) & (US$/Unit) Table 18. North America Wilms Tumor Protein Sales by Type (2021-2026) & (K Units) Table 19. North America Wilms Tumor Protein Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Wilms Tumor Protein Sales by Type (2021-2026) & (K Units) Table 21. Europe Wilms Tumor Protein Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Wilms Tumor Protein Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Wilms Tumor Protein Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Wilms Tumor Protein Sales by Type (2021-2026) & (K Units) Table 25. Latin America Wilms Tumor Protein Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Wilms Tumor Protein Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Wilms Tumor Protein Sales by Type (2021-2026) & (US$ Million) Table 28. Wilms Tumor Protein Industry Trends Table 29. Wilms Tumor Protein Industry Drivers Table 30. Wilms Tumor Protein Industry Opportunities and Challenges Table 31. Wilms Tumor Protein Industry Restraints Table 32. Global Wilms Tumor Protein Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Wilms Tumor Protein Revenue Market Share by Company (2021-2026) Table 34. Global Wilms Tumor Protein Sales by Company (2021-2026) & (K Units) Table 35. Global Wilms Tumor Protein Sales Share by Company (2021-2026) Table 36. Global Wilms Tumor Protein Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Wilms Tumor Protein Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Wilms Tumor Protein Major Company Production Sites and Headquarters Table 39. Global Wilms Tumor Protein Company, Product Type & Application Table 40. Global Wilms Tumor Protein Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Wilms Tumor Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Wilms Tumor Protein Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Wilms Tumor Protein Sales by Region (2021-2026) & (K Units) Table 45. Global Wilms Tumor Protein Sales Market Share in Volume by Region (2021-2026) Table 46. Global Wilms Tumor Protein Sales by Region (2021-2026) & (US$ Million) Table 47. Global Wilms Tumor Protein Sales Market Share in Value by Region (2021-2026) Table 48. Global Wilms Tumor Protein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Wilms Tumor Protein Sales by Region (2027-2032) & (K Units) Table 50. Global Wilms Tumor Protein Sales Market Share in Volume by Region (2027-2032) Table 51. Global Wilms Tumor Protein Sales by Region (2027-2032) & (US$ Million) Table 52. Global Wilms Tumor Protein Sales Market Share in Value by Region (2027-2032) Table 53. Global Wilms Tumor Protein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Wilms Tumor Protein Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Wilms Tumor Protein Sales by Application (2021-2026) & (K Units) Table 56. Global Wilms Tumor Protein Sales Market Share in Volume by Application (2021-2026) Table 57. Global Wilms Tumor Protein Sales by Application (2021-2026) & (US$ Million) Table 58. Global Wilms Tumor Protein Sales Market Share in Value by Application (2021-2026) Table 59. Global Wilms Tumor Protein Price by Application (2021-2026) & (US$/Unit) Table 60. Global Wilms Tumor Protein Sales by Application (2027-2032) & (K Units) Table 61. Global Wilms Tumor Protein Sales Market Share in Volume by Application (2027-2032) Table 62. Global Wilms Tumor Protein Sales by Application (2027-2032) & (US$ Million) Table 63. Global Wilms Tumor Protein Sales Market Share in Value by Application (2027-2032) Table 64. Global Wilms Tumor Protein Price by Application (2027-2032) & (US$/Unit) Table 65. North America Wilms Tumor Protein Sales by Application (2021-2026) & (K Units) Table 66. North America Wilms Tumor Protein Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Wilms Tumor Protein Sales by Application (2021-2026) & (K Units) Table 68. Europe Wilms Tumor Protein Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Wilms Tumor Protein Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Wilms Tumor Protein Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Wilms Tumor Protein Sales by Application (2021-2026) & (K Units) Table 72. Latin America Wilms Tumor Protein Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Wilms Tumor Protein Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Wilms Tumor Protein Sales by Application (2021-2026) & (US$ Million) Table 75. Sumitomo Dainippon Pharma Co Ltd Company Information Table 76. Sumitomo Dainippon Pharma Co Ltd Business Overview Table 77. Sumitomo Dainippon Pharma Co Ltd Wilms Tumor Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Sumitomo Dainippon Pharma Co Ltd Wilms Tumor Protein Product Portfolio Table 79. Sumitomo Dainippon Pharma Co Ltd Recent Development Table 80. GlaxoSmithKline Plc Company Information Table 81. GlaxoSmithKline Plc Business Overview Table 82. GlaxoSmithKline Plc Wilms Tumor Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. GlaxoSmithKline Plc Wilms Tumor Protein Product Portfolio Table 84. GlaxoSmithKline Plc Recent Development Table 85. Vaximm AG Company Information Table 86. Vaximm AG Business Overview Table 87. Vaximm AG Wilms Tumor Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Vaximm AG Wilms Tumor Protein Product Portfolio Table 89. Vaximm AG Recent Development Table 90. Sellas Life Sciences Group Ltd Company Information Table 91. Sellas Life Sciences Group Ltd Business Overview Table 92. Sellas Life Sciences Group Ltd Wilms Tumor Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Sellas Life Sciences Group Ltd Wilms Tumor Protein Product Portfolio Table 94. Sellas Life Sciences Group Ltd Recent Development Table 95. Otsuka Holdings Co Ltd Company Information Table 96. Otsuka Holdings Co Ltd Business Overview Table 97. Otsuka Holdings Co Ltd Wilms Tumor Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Otsuka Holdings Co Ltd Wilms Tumor Protein Product Portfolio Table 99. Otsuka Holdings Co Ltd Recent Development Table 100. Inovio Pharmaceuticals Inc Company Information Table 101. Inovio Pharmaceuticals Inc Business Overview Table 102. Inovio Pharmaceuticals Inc Wilms Tumor Protein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Inovio Pharmaceuticals Inc Wilms Tumor Protein Product Portfolio Table 104. Inovio Pharmaceuticals Inc Recent Development Table 105. North America Wilms Tumor Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 106. North America Wilms Tumor Protein Sales by Country (2021-2026) & (K Units) Table 107. North America Wilms Tumor Protein Sales Market Share by Country (2021-2026) Table 108. North America Wilms Tumor Protein Sales Forecast by Country (2027-2032) & (K Units) Table 109. North America Wilms Tumor Protein Sales Market Share Forecast by Country (2027-2032) Table 110. North America Wilms Tumor Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 111. North America Wilms Tumor Protein Market Size by Country (2021-2026) & (US$ Million) Table 112. North America Wilms Tumor Protein Market Share by Country (2021-2026) Table 113. North America Wilms Tumor Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 114. North America Wilms Tumor Protein Market Share Forecast by Country (2027-2032) Table 115. Europe Wilms Tumor Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 116. Europe Wilms Tumor Protein Sales by Country (2021-2026) & (K Units) Table 117. Europe Wilms Tumor Protein Sales Market Share by Country (2021-2026) Table 118. Europe Wilms Tumor Protein Sales Forecast by Country (2027-2032) & (K Units) Table 119. Europe Wilms Tumor Protein Sales Market Share Forecast by Country (2027-2032) Table 120. Europe Wilms Tumor Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 121. Europe Wilms Tumor Protein Market Size by Country (2021-2026) & (US$ Million) Table 122. Europe Wilms Tumor Protein Market Share by Country (2021-2026) Table 123. Europe Wilms Tumor Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 124. Europe Wilms Tumor Protein Market Share Forecast by Country (2027-2032) Table 125. Asia-Pacific Wilms Tumor Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 126. Asia-Pacific Wilms Tumor Protein Sales by Country (2021-2026) & (K Units) Table 127. Asia-Pacific Wilms Tumor Protein Sales Market Share by Country (2021-2026) Table 128. Asia-Pacific Wilms Tumor Protein Sales Forecast by Country (2027-2032) & (K Units) Table 129. Asia-Pacific Wilms Tumor Protein Sales Market Share Forecast by Country (2027-2032) Table 130. Asia-Pacific Wilms Tumor Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. Asia-Pacific Wilms Tumor Protein Market Size by Country (2021-2026) & (US$ Million) Table 132. Asia-Pacific Wilms Tumor Protein Market Share by Country (2021-2026) Table 133. Asia-Pacific Wilms Tumor Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. Asia-Pacific Wilms Tumor Protein Market Share Forecast by Country (2027-2032) Table 135. Latin America Wilms Tumor Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 136. Latin America Wilms Tumor Protein Sales by Country (2021-2026) & (K Units) Table 137. Latin America Wilms Tumor Protein Sales Market Share by Country (2021-2026) Table 138. Latin America Wilms Tumor Protein Sales Forecast by Country (2027-2032) & (K Units) Table 139. Latin America Wilms Tumor Protein Sales Market Share Forecast by Country (2027-2032) Table 140. Latin America Wilms Tumor Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Latin America Wilms Tumor Protein Market Size by Country (2021-2026) & (US$ Million) Table 142. Latin America Wilms Tumor Protein Market Share by Country (2021-2026) Table 143. Latin America Wilms Tumor Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Latin America Wilms Tumor Protein Market Share Forecast by Country (2027-2032) Table 145. Middle East and Africa Wilms Tumor Protein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. Middle East and Africa Wilms Tumor Protein Sales by Country (2021-2026) & (K Units) Table 147. Middle East and Africa Wilms Tumor Protein Sales Market Share by Country (2021-2026) Table 148. Middle East and Africa Wilms Tumor Protein Sales Forecast by Country (2027-2032) & (K Units) Table 149. Middle East and Africa Wilms Tumor Protein Sales Market Share Forecast by Country (2027-2032) Table 150. Middle East and Africa Wilms Tumor Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Middle East and Africa Wilms Tumor Protein Market Size by Country (2021-2026) & (US$ Million) Table 152. Middle East and Africa Wilms Tumor Protein Market Share by Country (2021-2026) Table 153. Middle East and Africa Wilms Tumor Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Middle East and Africa Wilms Tumor Protein Market Share Forecast by Country (2027-2032) Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Wilms Tumor Protein Distributors List Table 158. Wilms Tumor Protein Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Wilms Tumor Protein Image Figure 2. Global Wilms Tumor Protein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Wilms Tumor Protein Market Size (2021-2032) & (US$ Million) Figure 4. Global Wilms Tumor Protein Sales (2021-2032) & (K Units) Figure 5. OCV-501 Image Figure 6. Global OCV-501 Sales YoY Growth (2021-2032) & (K Units) Figure 7. INO-5401 Image Figure 8. Global INO-5401 Sales YoY Growth (2021-2032) & (K Units) Figure 9. GSK-2130579A Image Figure 10. Global GSK-2130579A Sales YoY Growth (2021-2032) & (K Units) Figure 11. Galinpepimut-S Image Figure 12. Global Galinpepimut-S Sales YoY Growth (2021-2032) & (K Units) Figure 13. Elatipepimut-S Image Figure 14. Global Elatipepimut-S Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Wilms Tumor Protein Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Wilms Tumor Protein Market Share by Type 2025 VS 2032 Figure 19. North America Wilms Tumor Protein Sales Market Share in Volume by Type in 2025 Figure 20. North America Wilms Tumor Protein Sales Market Share in Value by Type in 2025 Figure 21. Europe Wilms Tumor Protein Sales Market Share in Volume by Type in 2025 Figure 22. Europe Wilms Tumor Protein Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Wilms Tumor Protein Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Wilms Tumor Protein Sales Market Share in Value by Type in 2025 Figure 25. Latin America Wilms Tumor Protein Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Wilms Tumor Protein Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Wilms Tumor Protein Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Wilms Tumor Protein Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Wilms Tumor Protein Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Adrenal Gland Cancer Image Figure 32. Global Adrenal Gland Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 33. High-Grade Glioma Image Figure 34. Global High-Grade Glioma Sales YoY Growth (2021-2032) & (K Units) Figure 35. Peritoneal Cancer Image Figure 36. Global Peritoneal Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 37. Lung Cancer Image Figure 38. Global Lung Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 41. Global Wilms Tumor Protein Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Wilms Tumor Protein Market Share by Application 2025 VS 2032 Figure 43. North America Wilms Tumor Protein Sales Market Share in Volume by Application in 2025 Figure 44. North America Wilms Tumor Protein Sales Market Share in Value by Application in 2025 Figure 45. Europe Wilms Tumor Protein Sales Market Share in Volume by Application in 2025 Figure 46. Europe Wilms Tumor Protein Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Wilms Tumor Protein Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Wilms Tumor Protein Sales Market Share in Value by Application in 2025 Figure 49. Latin America Wilms Tumor Protein Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Wilms Tumor Protein Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Wilms Tumor Protein Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Wilms Tumor Protein Sales Market Share in Value by Application in 2025 Figure 53. North America Wilms Tumor Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. North America Wilms Tumor Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Wilms Tumor Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Wilms Tumor Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Wilms Tumor Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Europe Wilms Tumor Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Wilms Tumor Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Wilms Tumor Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Wilms Tumor Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Asia-Pacific Wilms Tumor Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Wilms Tumor Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Wilms Tumor Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Wilms Tumor Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Latin America Wilms Tumor Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Wilms Tumor Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Wilms Tumor Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Wilms Tumor Protein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 70. Middle East and Africa Wilms Tumor Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Wilms Tumor Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Wilms Tumor Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Wilms Tumor Protein Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Wilms Tumor Protein Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • OCV-501
  • INO-5401
  • GSK-2130579A
  • Galinpepimut-S
  • Elatipepimut-S
  • Others
Applications
  • Adrenal Gland Cancer
  • High-Grade Glioma
  • Peritoneal Cancer
  • Lung Cancer
  • Others
Companies covered
  • Sumitomo Dainippon Pharma Co Ltd
  • GlaxoSmithKline Plc
  • Vaximm AG
  • Sellas Life Sciences Group Ltd
  • Otsuka Holdings Co Ltd
  • Inovio Pharmaceuticals Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Wilms Tumor Protein Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Wilms Tumor Protein Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Wilms Tumor Protein Market by Type
  6. 1.3.1 OCV-501
  7. 1.3.2 INO-5401
  8. 1.3.3 GSK-2130579A
  9. 1.3.4 Galinpepimut-S
  10. 1.3.5 Elatipepimut-S
  11. 1.3.6 Others
  12. 1.4 Global Wilms Tumor Protein Market Size by Type
  13. 1.4.1 Global Wilms Tumor Protein Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Wilms Tumor Protein Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Wilms Tumor Protein Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Wilms Tumor Protein Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Wilms Tumor Protein Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Wilms Tumor Protein Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Wilms Tumor Protein Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Wilms Tumor Protein Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Wilms Tumor Protein Industry Trends
  2. 2.2 Wilms Tumor Protein Industry Drivers
  3. 2.3 Wilms Tumor Protein Industry Opportunities and Challenges
  4. 2.4 Wilms Tumor Protein Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Wilms Tumor Protein Revenue (2021-2026)
  2. 3.2 Global Top Players by Wilms Tumor Protein Sales (2021-2026)
  3. 3.3 Global Top Players by Wilms Tumor Protein Price (2021-2026)
  4. 3.4 Global Wilms Tumor Protein Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Wilms Tumor Protein Major Company Production Sites & Headquarters
  6. 3.6 Global Wilms Tumor Protein Company, Product Type & Application
  7. 3.7 Global Wilms Tumor Protein Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Wilms Tumor Protein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Wilms Tumor Protein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Wilms Tumor Protein Tier 1, Tier 2, and Tier 3
4 Wilms Tumor Protein Regional Status and Outlook
  1. 4.1 Global Wilms Tumor Protein Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Wilms Tumor Protein Historic Market Size by Region
  3. 4.2.1 Global Wilms Tumor Protein Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Wilms Tumor Protein Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Wilms Tumor Protein Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Wilms Tumor Protein Forecasted Market Size by Region
  7. 4.3.1 Global Wilms Tumor Protein Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Wilms Tumor Protein Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Wilms Tumor Protein Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Wilms Tumor Protein by Application
  1. 5.1 Wilms Tumor Protein Market by Application
  2. 5.1.1 Adrenal Gland Cancer
  3. 5.1.2 High-Grade Glioma
  4. 5.1.3 Peritoneal Cancer
  5. 5.1.4 Lung Cancer
  6. 5.1.5 Others
  7. 5.2 Global Wilms Tumor Protein Market Size by Application
  8. 5.2.1 Global Wilms Tumor Protein Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Wilms Tumor Protein Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Wilms Tumor Protein Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Wilms Tumor Protein Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Wilms Tumor Protein Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Wilms Tumor Protein Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Wilms Tumor Protein Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Wilms Tumor Protein Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sumitomo Dainippon Pharma Co Ltd
  2. 6.1.1 Sumitomo Dainippon Pharma Co Ltd Company Information
  3. 6.1.2 Sumitomo Dainippon Pharma Co Ltd Business Overview
  4. 6.1.3 Sumitomo Dainippon Pharma Co Ltd Wilms Tumor Protein Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sumitomo Dainippon Pharma Co Ltd Wilms Tumor Protein Product Portfolio
  6. 6.1.5 Sumitomo Dainippon Pharma Co Ltd Recent Developments
  7. 6.2 GlaxoSmithKline Plc
  8. 6.2.1 GlaxoSmithKline Plc Company Information
  9. 6.2.2 GlaxoSmithKline Plc Business Overview
  10. 6.2.3 GlaxoSmithKline Plc Wilms Tumor Protein Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Plc Wilms Tumor Protein Product Portfolio
  12. 6.2.5 GlaxoSmithKline Plc Recent Developments
  13. 6.3 Vaximm AG
  14. 6.3.1 Vaximm AG Company Information
  15. 6.3.2 Vaximm AG Business Overview
  16. 6.3.3 Vaximm AG Wilms Tumor Protein Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Vaximm AG Wilms Tumor Protein Product Portfolio
  18. 6.3.5 Vaximm AG Recent Developments
  19. 6.4 Sellas Life Sciences Group Ltd
  20. 6.4.1 Sellas Life Sciences Group Ltd Company Information
  21. 6.4.2 Sellas Life Sciences Group Ltd Business Overview
  22. 6.4.3 Sellas Life Sciences Group Ltd Wilms Tumor Protein Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sellas Life Sciences Group Ltd Wilms Tumor Protein Product Portfolio
  24. 6.4.5 Sellas Life Sciences Group Ltd Recent Developments
  25. 6.5 Otsuka Holdings Co Ltd
  26. 6.5.1 Otsuka Holdings Co Ltd Company Information
  27. 6.5.2 Otsuka Holdings Co Ltd Business Overview
  28. 6.5.3 Otsuka Holdings Co Ltd Wilms Tumor Protein Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Otsuka Holdings Co Ltd Wilms Tumor Protein Product Portfolio
  30. 6.5.5 Otsuka Holdings Co Ltd Recent Developments
  31. 6.6 Inovio Pharmaceuticals Inc
  32. 6.6.1 Inovio Pharmaceuticals Inc Company Information
  33. 6.6.2 Inovio Pharmaceuticals Inc Business Overview
  34. 6.6.3 Inovio Pharmaceuticals Inc Wilms Tumor Protein Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Inovio Pharmaceuticals Inc Wilms Tumor Protein Product Portfolio
  36. 6.6.5 Inovio Pharmaceuticals Inc Recent Developments
7 North America by Country
  1. 7.1 North America Wilms Tumor Protein Sales by Country
  2. 7.1.1 North America Wilms Tumor Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Wilms Tumor Protein Sales by Country (2021-2026)
  4. 7.1.3 North America Wilms Tumor Protein Sales Forecast by Country (2027-2032)
  5. 7.2 North America Wilms Tumor Protein Market Size by Country
  6. 7.2.1 North America Wilms Tumor Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Wilms Tumor Protein Market Size by Country (2021-2026)
  8. 7.2.3 North America Wilms Tumor Protein Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Wilms Tumor Protein Sales by Country
  2. 8.1.1 Europe Wilms Tumor Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Wilms Tumor Protein Sales by Country (2021-2026)
  4. 8.1.3 Europe Wilms Tumor Protein Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Wilms Tumor Protein Market Size by Country
  6. 8.2.1 Europe Wilms Tumor Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Wilms Tumor Protein Market Size by Country (2021-2026)
  8. 8.2.3 Europe Wilms Tumor Protein Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Wilms Tumor Protein Sales by Country
  2. 9.1.1 Asia-Pacific Wilms Tumor Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Wilms Tumor Protein Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Wilms Tumor Protein Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Wilms Tumor Protein Market Size by Country
  6. 9.2.1 Asia-Pacific Wilms Tumor Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Wilms Tumor Protein Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Wilms Tumor Protein Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Wilms Tumor Protein Sales by Country
  2. 10.1.1 South America Wilms Tumor Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Wilms Tumor Protein Sales by Country (2021-2026)
  4. 10.1.3 South America Wilms Tumor Protein Sales Forecast by Country (2027-2032)
  5. 10.2 South America Wilms Tumor Protein Market Size by Country
  6. 10.2.1 South America Wilms Tumor Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Wilms Tumor Protein Market Size by Country (2021-2026)
  8. 10.2.3 South America Wilms Tumor Protein Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Wilms Tumor Protein Sales by Country
  2. 11.1.1 Middle East and Africa Wilms Tumor Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Wilms Tumor Protein Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Wilms Tumor Protein Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Wilms Tumor Protein Market Size by Country
  6. 11.2.1 Middle East and Africa Wilms Tumor Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Wilms Tumor Protein Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Wilms Tumor Protein Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Wilms Tumor Protein Value Chain Analysis
  2. 12.1.1 Wilms Tumor Protein Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Wilms Tumor Protein Production Mode & Process
  7. 12.2 Wilms Tumor Protein Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Wilms Tumor Protein Distributors
  10. 12.2.3 Wilms Tumor Protein Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst